References
- 1. Fennerty MB. Helicobacter pylori. Arch Intern Med. 1994; 254:721-7.10.1001/archinte.1994.00420070021003
- 2. Marshall B. Helicobacter pylori. Am J Gastroenterol. 1994; 89:S116-28.
- 3. Colin WH, Richard HH. Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol. 1998; 93:2330-8.10.1016/S0002-9270(98)00565-6
- 4. Atherton JC. Non-endoscopic tests in the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther. 1997; 11 (Suppl 1):11-20.10.1046/j.1365-2036.11.s1.3.x
- 5. CAM Stedman, ML Barclay. Review article: comparison of the pharmacokinetics. Acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther. 2000; 14:963-78.10.1046/j.1365-2036.2000.00788.x
- 6. John H. The proton pump inhibitors: similarities and differences. Clinical Therapeutics. 2000; 22:266-79.10.1016/S0149-2918(00)80032-6
- 7. Chey WD, Spybrook M, Carpenter S, Nostrant TT, Elta GH, Scheiman JM. Prolonged effect of omeprazole on the 14C-urea breath test. Am J Gastroenterol. 1996; 91:89-92.
- 8. Connor SJ, Seow F, Ngu MC, Katelaris PH. The effect of dosing with omeprazole on the accuracy of 13C-urea breath test in Helicobacter pylori-infected subjects. Aliment Pharmacol Ther. 1999; 13:1287-93.10.1046/j.1365-2036.1999.00601.x10540042
- 9. Savirino V, Bisso G, Pivari M, Zentilin P, Bilardi C, Dulbecco P, et al. Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine and omeprazole. Aliment Pharmacol Ther. 2000; 14:291-7.10.1046/j.1365-2036.2000.00721.x10735921
- 10. Parente F, Sainaghi M, Sangaletti O, Imbesi V, Maconi G, Anderloni A et al. Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the 13C-urea breath test. Aliment Pharmacol Ther. 2002; 16:553-7.10.1046/j.1365-2036.2002.01192.x11876710
- 11. Shirin H, Frenkel D, Shevah O, Levine A, Bruck R, Moss S, et al. Effect of proton pump inhibitors on the continuous real time 13C-urea breath test. Am J Gastroenterol. 2003; 98:46-50.10.1111/j.1572-0241.2003.07187.x12526935
- 12. Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS, et al. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenteol. 2003; 98:1005-9.10.1111/j.1572-0241.2003.07426.x12809820
- 13. Graham DY. An alternative explanation of the effect of citric acid on proton pump inhibitors-associated false negative urea breath tests. Am J Gastroenterol. 2001; 96:3032-9.10.1111/j.1572-0241.2001.04691.x
- 14. Klein PD, Malaty HM, Martin RF, Graham KS, Genta RM, Graham DY. et al. Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol. 1996; 91: 690-4.
- 15. Desroches JJ, Lahaie RG, Picard M, Morais J, Dumont A, Gaudreau C, et al. Methodological validation and clinical usefulness of carbon-14 urea breath test for documentation of presence and eradication of Helicobacter pylori infection. J Nucl Med. 1997; 38: 1141-5.
- 16. Katelaris PH, Jone B. Testing for Helicobacter pylori infection after antibiotic treatment. Am J Gastroenterol. 1997; 92:1245-7.
- 17. Levine A, Shevah O, Shabat-Sehayek V, Aeed H, Boaz M, Moss SF, et al. Masking of 13C-urea breath test by proton pump inhibitors is dependent on type of medication: compare between omeprazole, pantoprazole, lansoprazole and esomeprazole. Aliment Pharmacol Ther. 2004; 20:117-22.10.1111/j.1365-2036.2004.02021.x15225178
- 18. Stack WA, Kniffon A, Thirlwell D, Cockayme A, Jenkins D, Hawkey CJ, et al. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. Am J Gastroenterol. 1998; 93:1909-13.10.1111/j.1572-0241.1998.00582.x9772054
- 19. Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A. Rebamipide: overview of its mechanism of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sc. 1998; 43 (9 suppl):S5-13.
- 20. Sakurai K, Osaka T, Yamasaki K. Rebamipide induces recurrence of experimental gastric ulcers: role of free radicals and neutrophils. Dig Dis Sc. 2005; 50 (Suppl 1):S90-6.10.1007/s10620-005-2812-516184427
- 21. Arakawa T, Higuchi K, Fujiwara Y, Watanabe T, Tominaga K, Sasaki E, et al. 15th anniversary of rebamipide: looking ahead to new mechanism and new applications. Dig Dis Sc. 2005; 50 (Suppl 1):S3-11.10.1007/s10620-005-2800-916184418
- 22. Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Fujioka T, et al. Influence of anti-ulcer drugs used in Japan on the result of 13C-urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol. 2003; 38:937-41.10.1007/s00535-003-1176-x14614600
- 23. Adachi K, Fujishiro H, Mihara T, komazawa Y, Kinoshita Y. Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection. J Gastroenterol Hepatol. 2003; 18:168-71. 10.1046/j.1440-1746.2003.02922.x12542601
- 24. Hayashi S, Sugiyama T, Amano K, Isogai E, Aihara M, Kikuchi M, et al. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells. Antimicrob Agents Chemther. 1998; 42:1895-9.10.1128/AAC.42.8.18951057069687380